@misc{indiciae8217852a344f,
  title = {Human loss-of-function variants suggest that partial LRRK2 inhibition is a safe therapeutic strategy for Parkinsons disease},
  author = {Whiffin, N. and Armean, I. M. and Kleinman, A. and Marshall, J. L. and Minikel, E. V. and Karczewski, K. J. and Cummings, B. B. and Francioli, L. and Laricchia, K. and Wang, Q. and Guan, A. and Alipanahi, B. and Morrison, P. and Baptista, M. A. and Merchant, K. M. and Genome Aggregation Database Production Team, and Genome Aggregation Database Consortium, and Ware, J. S. and Havulinna, A. S. and Iliadou, B. and Lee, J.-J. and Nadkarni, G. N. and Whiteman, C. and the 23andMe Research Team, and Daly, M. and Esko, T. and Hultman, C. and Loos, R. J. and Milani, L. and Palotie, A. and Pato, C. and Pato, M. and Saleheen, D. and Sullivan, P. F. and Alföldi, J. and Cannon, P. and MacArthur, D. G.},
  year = {2019},
  doi = {10.1101/561472},
  url = {https://www.biorxiv.org/content/10.1101/561472v1},
  note = {Source identifier: 10.1101/561472}
}